ALK status testing in non-small cell lung carcinoma: Correlation between ultrasensitive IHC and FISH

Journal of Molecular Diagnostics

Volumn 15, Issue 3, 2013, Pages 341-346

  Minca, Eugen C ^a   Portier, Bryce P ^a   Wang, Zhen ^a   Lanigan, Christopher ^a   Farver, Carol F ^a   Feng, Yan ^b   Ma, Patrick C ^b   Arrossi, Valeria A ^a   Pennell, Nathan A ^b   Tubbs, Raymond R ^a  

^a Pathology and Laboratory Medicine Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALK GENE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; PYRAZOLES; PYRIDINES; RECEPTOR PROTEIN-TYROSINE KINASES; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 84876482049     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.01.004     Document Type: Article

References (21)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, and M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
3. L. Horn, and W. Pao EML4-ALK: honing in on a new target in non-small-cell lung cancer J Clin Oncol 27 2009 4232 4235
4. K. Rikova, A. Guo, Q. Zeng, A. Possemato, J. Yu, H. Haack, J. Nardone, K. Lee, C. Reeves, Y. Li, Y. Hu, Z. Tan, M. Stokes, L. Sullivan, J. Mitchell, R. Wetzel, J. Macneill, J.M. Ren, J. Yuan, C.E. Bakalarski, J. Villen, J.M. Kornhauser, B. Smith, D. Li, X. Zhou, S.P. Gygi, T.L. Gu, R.D. Polakiewicz, J. Rush, and M.J. Comb Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 2007 1190 1203
5. M. Soda, Y.L. Choi, M. Enomoto, S. Takada, Y. Yamashita, S. Ishikawa, S. Fujiwara, H. Watanabe, K. Kurashina, H. Hatanaka, M. Bando, S. Ohno, Y. Ishikawa, H. Aburatani, T. Niki, Y. Sohara, Y. Sugiyama, and H. Mano Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
6. E.L. Kwak, Y.J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, R.G. Maki, S.H. Ou, B.J. Dezube, P.A. Janne, D.B. Costa, M. Varella-Garcia, W.H. Kim, T.J. Lynch, P. Fidias, H. Stubbs, J.A. Engelman, L.V. Sequist, W. Tan, L. Gandhi, M. Mino-Kenudson, G.C. Wei, S.M. Shreeve, M.J. Ratain, J. Settleman, J.G. Christensen, D.A. Haber, K. Wilner, R. Salgia, G.I. Shapiro, J.W. Clark, and A.J. Iafrate Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
7. A.T. Shaw, B.Y. Yeap, M. Mino-Kenudson, S.R. Digumarthy, D.B. Costa, R.S. Heist, B. Solomon, H. Stubbs, S. Admane, U. McDermott, J. Settleman, S. Kobayashi, E.J. Mark, S.J. Rodig, L.R. Chirieac, E.L. Kwak, T.J. Lynch, and A.J. Iafrate Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK J Clin Oncol 27 2009 4247 4253
8. S.J. Rodig, M. Mino-Kenudson, S. Dacic, B.Y. Yeap, A. Shaw, J.A. Barletta, H. Stubbs, K. Law, N. Lindeman, E. Mark, P.A. Janne, T. Lynch, B.E. Johnson, A.J. Iafrate, and L.R. Chirieac Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population Clin Cancer Res 15 2009 5216 5223
9. S.W. Morris, M.N. Kirstein, M.B. Valentine, K.G. Dittmer, D.N. Shapiro, D.L. Saltman, and A.T. Look Fusion of a kinase gene. ALK, to a nucleolar protein gene NPM, in non-Hodgkin's lymphoma Science 263 1994 1281 1284
10. K.A. Cataldo, S.M. Jalal, M.E. Law, S.M. Ansell, D.J. Inwards, M. Fine, D.A. Arber, K.A. Pulford, and J.G. Strickler Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue Am J Surg Pathol 23 1999 1386 1392
11. M. Mino-Kenudson, L.R. Chirieac, K. Law, J.L. Hornick, N. Lindeman, E.J. Mark, D.W. Cohen, B.E. Johnson, P.A. Janne, A.J. Iafrate, and S.J. Rodig A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry Clin Cancer Res 16 2010 1561 1571
12. K. Takeuchi, Y.L. Choi, Y. Togashi, M. Soda, S. Hatano, K. Inamura, S. Takada, T. Ueno, Y. Yamashita, Y. Satoh, S. Okumura, K. Nakagawa, Y. Ishikawa, and H. Mano KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer Clin Cancer Res 15 2009 3143 3149
13. I.A. Sokolova, K.C. Halling, R.B. Jenkins, H.M. Burkhardt, R.G. Meyer, S.A. Seelig, and W. King The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine J Mol Diagn 2 2000 116 123
14. M. Skacel, J.D. Pettay, E.K. Tsiftsakis, G.W. Procop, C.V. Biscotti, and R.R. Tubbs Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides Anal Quant Cytol Histol 23 2001 381 387
15. E.S. Yi, J.M. Boland, J.J. Maleszewski, A.C. Roden, A.M. Oliveira, M.C. Aubry, M.R. Erickson-Johnson, B.L. Caron, Y. Li, H. Tang, S. Stoddard, J. Wampfler, K. Kulig, and P. Yang Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: iHC score algorithm for FISH J Thorac Oncol 6 2011 459 465
16. J.H. Paik, G. Choe, H. Kim, J.Y. Choe, H.J. Lee, C.T. Lee, J.S. Lee, S. Jheon, and J.H. Chung Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization J Thorac Oncol 6 2011 466 472
17. D.R. Camidge, S.A. Kono, A. Flacco, A.C. Tan, R.C. Doebele, Q. Zhou, L. Crino, W.A. Franklin, and M. Varella-Garcia Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment Clin Cancer Res 16 2010 5581 5590
18. N. Peled, G. Palmer, F.R. Hirsch, M.W. Wynes, M. Ilouze, M. Varella-Garcia, L. Soussan-Gutman, G.A. Otto, P.J. Stephens, J.S. Ross, M.T. Cronin, D. Lipson, and V.A. Miller Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer J Thorac Oncol 7 2012 e14 e16
19. M.L. Wallander, K.B. Geiersbach, S.R. Tripp, and L.J. Layfield Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing Arch Pathol Lab Med 136 2012 796 803
20. M.P. Martelli, G. Sozzi, L. Hernandez, V. Pettirossi, A. Navarro, D. Conte, P. Gasparini, F. Perrone, P. Modena, U. Pastorino, A. Carbone, A. Fabbri, A. Sidoni, S. Nakamura, M. Gambacorta, P.L. Fernandez, J. Ramirez, J.K. Chan, W.F. Grigioni, E. Campo, S.A. Pileri, and B. Falini EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues The Am J Pathol 174 2009 661 670
21. A. McLeer-Florin, D. Moro-Sibilot, A. Melis, D. Salameire, C. Lefebvre, F. Ceccaldi, F. de Fraipont, E. Brambilla, and S. Lantuejoul Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study J Thorac Oncol 7 2012 348 354